Overbrook Management Corp Has $353,000 Holdings in Colgate-Palmolive (CL)

Overbrook Management Corp boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 39.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,920 shares of the company’s stock after buying an additional 1,400 shares during the period. Overbrook Management Corp’s holdings in Colgate-Palmolive were worth $353,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in CL. Advisor Group Inc. raised its holdings in Colgate-Palmolive by 24.5% in the 4th quarter. Advisor Group Inc. now owns 77,352 shares of the company’s stock valued at $5,838,000 after buying an additional 15,212 shares during the last quarter. Summit Global Investments raised its holdings in Colgate-Palmolive by 27.8% in the 1st quarter. Summit Global Investments now owns 60,666 shares of the company’s stock valued at $4,348,000 after buying an additional 13,191 shares during the last quarter. Gradient Investments LLC raised its holdings in Colgate-Palmolive by 6.5% in the 4th quarter. Gradient Investments LLC now owns 106,168 shares of the company’s stock valued at $8,010,000 after buying an additional 6,478 shares during the last quarter. Arizona State Retirement System raised its holdings in Colgate-Palmolive by 2.4% in the 4th quarter. Arizona State Retirement System now owns 241,150 shares of the company’s stock valued at $18,195,000 after buying an additional 5,588 shares during the last quarter. Finally, Two Sigma Advisers LP raised its holdings in Colgate-Palmolive by 25.1% in the 4th quarter. Two Sigma Advisers LP now owns 1,513,711 shares of the company’s stock valued at $114,209,000 after buying an additional 303,690 shares during the last quarter. Hedge funds and other institutional investors own 73.23% of the company’s stock.

A number of research analysts recently issued reports on the stock. Citigroup dropped their price objective on shares of Colgate-Palmolive from $80.00 to $73.00 and set a “neutral” rating for the company in a report on Tuesday, May 1st. Barclays set a $70.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Monday, April 30th. Argus upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Friday, May 25th. They noted that the move was a valuation call. ValuEngine lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Finally, Sanford C. Bernstein reiterated a “market perform” rating and issued a $72.00 price objective on shares of Colgate-Palmolive in a report on Thursday, May 24th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $76.08.

In other news, Vice Chairman Franck J. Moison sold 80,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 15th. The shares were sold at an average price of $61.75, for a total transaction of $4,940,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Daniel B. Marsili sold 19,500 shares of the firm’s stock in a transaction that occurred on Monday, April 16th. The stock was sold at an average price of $71.85, for a total transaction of $1,401,075.00. Following the sale, the insider now directly owns 77,935 shares of the company’s stock, valued at approximately $5,599,629.75. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 142,079 shares of company stock valued at $8,981,683. Company insiders own 1.02% of the company’s stock.

Colgate-Palmolive stock opened at $62.57 on Thursday. The company has a debt-to-equity ratio of 64.85, a current ratio of 1.08 and a quick ratio of 0.75. Colgate-Palmolive has a 52-week low of $61.28 and a 52-week high of $77.91. The company has a market cap of $54.34 billion, a price-to-earnings ratio of 21.80, a PEG ratio of 2.50 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, April 27th. The company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 13.30% and a return on equity of 1,486.69%. The firm had revenue of $4 billion during the quarter, compared to analyst estimates of $4.01 billion. During the same quarter last year, the business earned $0.67 EPS. The company’s revenue was up 6.4% compared to the same quarter last year. analysts forecast that Colgate-Palmolive will post 3.16 earnings per share for the current year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply